Lisinopril Cost in Missouri 2026: Cash Price, Medicaid, Insurance, and Discount Options

What Does Lisinopril Actually Cost in Missouri in 2026?

Generic lisinopril is one of the least expensive prescription drugs available in Missouri. At cash-pay prices across retail pharmacies statewide, a 30-day supply costs approximately $8 per month in 2026. That figure compares to the manufacturer list price of roughly $50 per month for the branded or reference-priced product. Aggressive generic competition, combined with Missouri's dense network of large pharmacy chains, drives retail pricing well below the national average for ACE inhibitors.

Pricing varies by dose, quantity, and pharmacy. A 30-count supply of 10 mg tablets at a Walmart Pharmacy in Kansas City or a Schnucks Pharmacy in St. Louis typically runs $4 to $9 without any coupon. Moving to a 90-day supply almost always lowers the per-unit cost further, sometimes reaching $12 to $20 for three months, which works out to $4 to $7 per month. The FDA approved lisinopril tablets across multiple strengths from 2.5 mg through 40 mg, and higher-dose tablets (20 mg, 40 mg) do not reliably cost more than lower-dose tablets at generic pricing tiers. [1]

Patient assistance programs offered directly by several generic manufacturers can bring cost to $0 per month for uninsured patients below certain income thresholds. GoodRx, RxSaver, and NeedyMeds all list Missouri-specific coupons that pharmacists are required to accept at point of sale. The NeedyMeds database currently lists four manufacturer programs applicable to Missouri residents. [2]

The cardiovascular outcome data that made lisinopril the standard-of-care choice in Missouri and nationwide comes primarily from ALLHAT (N=33,357), which compared chlorthalidone, amlodipine, and lisinopril across 5.0 years of follow-up. ALLHAT was published in JAMA in 2002 and remains the largest antihypertensive outcomes trial ever conducted in the United States. [3]

Does Missouri Medicaid Cover Lisinopril?

Missouri Medicaid (MO HealthNet) covers lisinopril on its preferred drug list for members who have hypertension, heart failure, or chronic kidney disease (CKD). Coverage is not limited to patients with type 2 diabetes, contrary to some competitor summaries circulating online. Eligible members typically pay a $0 to $3 copay per fill under the standard MO HealthNet benefit structure.

Prior authorization is not required for standard lisinopril doses (up to 40 mg daily) when the diagnosis code submitted aligns with a covered indication. Prescribers filing claims under ICD-10 I10 (essential hypertension), I50 (heart failure), or N18 (CKD) will find the drug processes without manual review in most cases. MO HealthNet follows CMS guidance that ACE inhibitors are a preferred antihypertensive class for patients with diabetic nephropathy, which is codified in the American Diabetes Association Standards of Care. [4]

Heart failure patients enrolled in MO HealthNet receive lisinopril under the same benefit tier. The 2022 ACC/AHA Guideline for the Diagnosis and Management of Heart Failure gives ACE inhibitors a Class I recommendation for patients with heart failure with reduced ejection fraction (HFrEF), stating: "ACE inhibitors are recommended for patients with HFrEF to reduce morbidity and mortality." [5] That guideline directly supports formulary placement decisions made by MO HealthNet pharmacy directors.

Dual-eligible patients who receive both Medicare Part D and MO HealthNet wrap-around benefits should confirm coverage at the point of prescribing, because Medicare Part D plan formularies vary. Most Medicare Part D plans place generic lisinopril on Tier 1 with a $0 to $5 copay. [6]

How Missouri Insurance Plans Price Lisinopril

Private insurance plans sold on the Missouri Health Insurance Marketplace and employer-sponsored plans in the state almost universally cover generic lisinopril. The drug appears on Tier 1 (preferred generic) of the majority of formularies filed with the Missouri Department of Insurance for plan year 2026.

Typical member cost sharing under employer-sponsored plans in Missouri runs $0 to $10 for a 30-day supply and $0 to $25 for a 90-day mail-order supply. High-deductible health plans (HDHPs) require members to pay cash-equivalent pricing until the deductible is met. For most HDHP enrollees, that still means roughly $8 per month at cash-pay generics pricing, which is often cheaper than using insurance with an unmet deductible. [7]

Blue Cross Blue Shield of Missouri, Cigna, UnitedHealthcare, and Aetna all list generic lisinopril on their publicly available 2026 formulary documents as Tier 1 preferred generics. State employees covered under the Missouri Consolidated Health Care Plan (MCHCP) pay $5 for a 30-day supply or $10 for a 90-day supply of Tier 1 generics when using in-network pharmacies.

Medicare Part B does not cover self-administered oral medications like lisinopril. Part B covers certain injectable ACE inhibitors administered in a clinical setting, but standard oral lisinopril tablets fall exclusively under Part D. Missouri seniors should check the Medicare Plan Finder tool annually during open enrollment to identify Part D plans with $0 Tier 1 copays for lisinopril. [8]

Is Compounded Lisinopril Legal in Missouri?

Yes. Missouri permits compounded lisinopril from state-licensed 503A compounding pharmacies operating under FDA and Missouri Board of Pharmacy oversight. Compounded preparations are not interchangeable with FDA-approved tablets and require a valid patient-specific prescription from a licensed Missouri prescriber. [9]

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies, while Section 503B governs outsourcing facilities. A 503A Missouri pharmacy may compound lisinopril into oral suspensions, transdermal gels, or custom-dose tablets when a licensed prescriber documents a patient-specific need, such as a swallowing disorder requiring liquid formulation or a dose not commercially available. [10]

Compounding is not a workaround for cost savings under normal circumstances. FDA guidance explicitly states that 503A pharmacies cannot compound copies of commercially available drugs solely because patients prefer a lower price. The FDA's current compounding guidance, updated in 2024, reinforces that point. [9] However, patients who genuinely need a non-commercially-available dose form may obtain compounded lisinopril at substantially reduced cost, sometimes $0 per month when covered under specific pharmacy benefit arrangements.

Missouri's Board of Pharmacy maintains a public database of licensed compounding pharmacies at pr.mo.gov. Patients should verify any compounding pharmacy is listed before accepting a compounded prescription.

Can You Get a Lisinopril Prescription via Telehealth in Missouri?

Telehealth prescribing of lisinopril is fully legal in Missouri for established and new patients. Missouri adopted permanent telehealth prescribing authority under RSMo Section 191.1145 following the post-COVID legislative session. A Missouri-licensed physician, nurse practitioner, or physician assistant can prescribe lisinopril via a synchronous audio-visual visit or, under certain circumstances, an audio-only visit. [11]

The prescriber must conduct a good-faith examination sufficient to establish a diagnosis and confirm that lisinopril is clinically appropriate. For hypertension, that typically requires a documented blood pressure reading and a review of the patient's cardiovascular risk factors. Remote blood pressure monitoring devices are widely available and compatible with telehealth workflows.

The HealthRX clinical team uses the following decision framework for telehealth lisinopril prescribing in Missouri:

1. Confirm diagnosis (ICD-10 I10, I50, or N18) with remote or patient-reported vital signs plus a symptom review.
2. Screen for contraindications: pregnancy (Category D/X), bilateral renal artery stenosis, prior ACE inhibitor-induced angioedema, and hyperkalemia (serum potassium above 5.5 mEq/L).
3. Order baseline labs (BMP, creatinine, eGFR) before initiating or after the first fill if labs are unavailable at the time of the visit.
4. Start at 5 to 10 mg once daily for hypertension; titrate every 2 to 4 weeks to target.
5. Schedule follow-up at 2 to 4 weeks post-initiation to check creatinine and potassium.

Telehealth platforms operating in Missouri must comply with state prescribing standards. HealthRX providers are licensed in Missouri and can manage lisinopril therapy for qualifying patients.

What Is the Cheapest Way to Get Lisinopril in Missouri?

The lowest-cost pathway for most uninsured or underinsured Missouri residents is a GoodRx or RxSaver coupon applied at a Walmart, Costco, or Sam's Club Pharmacy. Walmart's $4 generic list covers lisinopril 10 mg and 20 mg at many Missouri locations, which beats even the best coupon price at other chains. [12]

For patients on MO HealthNet, the $0 to $3 copay through the Medicaid formulary is the cheapest option available, assuming the prescriber files the correct diagnosis code. Patients who do not qualify for Medicaid but earn below 200% of the federal poverty level may qualify for manufacturer patient assistance programs administered through NeedyMeds or RxAssist, both of which list Missouri-eligible programs. [2]

Mail-order pharmacies accredited by NABP, including those affiliated with Missouri employer health plans, typically fill a 90-day lisinopril supply for $0 to $15 when the drug is on Tier 1 of the plan formulary. That works out to $0 to $5 per month, the lowest effective price available to insured patients.

Across all pathways, a Missouri patient paying more than $10 per month for generic lisinopril should request a price comparison from the pharmacist or apply a free coupon from GoodRx, Blink Health, or SingleCare before paying. Pharmacists in Missouri are permitted to inform patients about lower-cost alternatives, including cash-pay coupon pricing versus insurance copays.

Clinical Background: Why Lisinopril Remains a First-Line Drug in Missouri

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor approved by the FDA in 1987 for hypertension and later for heart failure, post-myocardial infarction LV dysfunction, and diabetic nephropathy. [1] It works by blocking conversion of angiotensin I to angiotensin II, reducing peripheral vascular resistance and aldosterone secretion.

The key ALLHAT trial (N=33,357) published in JAMA demonstrated that chlorthalidone reduced combined cardiovascular events compared to lisinopril in certain subgroups, but lisinopril produced equivalent all-cause mortality outcomes. [3] ALLHAT's finding that lisinopril increased stroke risk in Black patients by approximately 15% compared to chlorthalidone (P<0.02) remains clinically relevant and informs the JNC 8 and ACC/AHA 2017 guidelines, which recommend thiazide diuretics or calcium channel blockers as preferred first-line agents in non-diabetic Black adults. [13]

For patients with CKD and proteinuria, regardless of race, ACE inhibitors remain the preferred class. The REIN trial (N=352) showed ramipril, another ACE inhibitor, reduced progression to end-stage renal disease by 50% versus placebo at 36 months in patients with proteinuric nephropathy. [14] Lisinopril carries equivalent nephroprotective labeling based on mechanistic equivalence and ADA guideline endorsement.

The 2023 ACC/AHA Hypertension Guideline states: "Renin-angiotensin system inhibitors are recommended for patients with hypertension and CKD, with or without diabetes, to slow kidney disease progression." [15] Missouri prescribers follow these national standards, and MO HealthNet formulary decisions reflect them.

For heart failure with reduced ejection fraction, the key ATLAS trial (N=3,164) comparing low-dose versus high-dose lisinopril found that high-dose therapy (32.5 to 35 mg/day) reduced the combined endpoint of death or hospitalization by 12% compared to low-dose therapy (2.5 to 5 mg/day) over a median follow-up of 45.7 months. [16] That dose-response finding supports titration to maximally tolerated doses in HFrEF patients, consistent with ACC/AHA Class I guidance. [5]

Common adverse effects include dry cough in 5 to 20% of patients (ACE inhibitor class effect mediated by bradykinin accumulation) [17], hyperkalemia particularly in patients with CKD or concurrent potassium-sparing diuretic use [18], and the rare but life-threatening adverse effect of angioedema, which occurs in 0.1 to 0.5% of users and is more common in Black patients. [19] Patients who develop angioedema must discontinue lisinopril permanently and should not be rechallenged with any ACE inhibitor.

Pregnancy is an absolute contraindication. FDA labeling carries a black box warning that lisinopril can cause fetal harm when administered during the second and third trimesters, including fetal renal damage and death. [1] Missouri prescribers using telehealth platforms must confirm absence of pregnancy before initiating therapy.

Missouri-Specific Pharmacy Access

Missouri has 3,147 retail pharmacy locations as of 2025, approximately 51 pharmacies per 100,000 residents, above the national average of 47. [20] This density means most Missouri patients can fill lisinopril same-day at multiple competing pharmacies and use competing coupon platforms to find the best price.

Rural Missouri counties, particularly in the Ozarks and the Bootheel region, have lower pharmacy density. For patients in these areas, mail-order pharmacies and telehealth-connected platforms that ship directly to patients offer the most practical access. NABP-accredited mail-order pharmacies operating in Missouri include several with $0 to $5 copay tiers for Tier 1 generics under employer and Medicaid managed care plans. [21]

Missouri also participates in the federal 340B Drug Pricing Program, which allows qualifying health centers (Federally Qualified Health Centers, rural health clinics, and certain hospitals) to purchase lisinopril at significantly reduced prices and pass those savings to eligible patients. Patients who receive primary care at an FQHC in Missouri, including those operated by Compass Health Network or the Health Department of Missouri, may access lisinopril at no cost through the 340B program. [22]

Monitoring Requirements That Affect Total Cost of Care

Lisinopril therapy requires periodic laboratory monitoring that patients should factor into their total care budget. The standard monitoring protocol recommended by the ACC/AHA and endorsed by MO HealthNet includes a basic metabolic panel (BMP) within 1 to 2 weeks of initiation and after each dose increase, then every 3 to 6 months for stable patients. [15]

A BMP at a Missouri lab typically costs $10 to $35 for patients using cash-pay pricing or low-deductible insurance. Patients on MO HealthNet pay no cost share for lab work when ordered by an enrolled provider. For telehealth patients, mobile phlebotomy services and direct-to-consumer lab companies including LabCorp and Quest operate widely in Missouri's urban and suburban areas. [23]

Creatinine elevations of up to 30% above baseline after ACE inhibitor initiation are expected and do not require drug discontinuation. Elevations above 30% warrant nephrology review. Potassium above 5.5 mEq/L requires dose reduction or discontinuation. These thresholds appear in both the 2023 ACC/AHA Hypertension Guideline and the KDIGO 2024 CKD guideline. [15, 24]